Researcher
Marc Peeters
- Research Expertise (University of Antwerp):My expertise is in the field of oncology or cancer research. It is mainly focused on clinical translational research. This domain is very broad and ranges from bio-research to clinical studies
- Keywords (University of Antwerp):ONCOLOGY, Medicine
- Disciplines (Ghent University):Endocrinology and metabolic diseases, Paediatrics and neonatology, Nursing
- Disciplines (University of Antwerp):Cancer therapy, Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention
- Research techniques (University of Antwerp):Making protocols for studies. (Statistical) analysis of results
- Users of research expertise (University of Antwerp):Other researchers in the field. Students Pharma and Biotech companies
- See also: Marc Peeters (Ghent University)
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Responsible
From1 Oct 2009 → 31 Dec 2018 - Department of Internal medicine (Department)
Member
From1 Oct 2000 → 30 Sep 2018
Projects
1 - 10 of 67
- Dawn of a new era in drug discovery: the symphony of AI-guided small molecule design with 3D patient-derived tumor organoids.From1 Jan 2024 → TodayFunding: IOF - technology concept exploration
- Trapped ion mobility quadrupole time of flight mass spectrometer hyphenated to automated high throughput liquid chromatography.From30 Jun 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Neuroendocrine neoplasms from bench to bedside: unravelling personalised strategies through the integration of clinical data and patientderived organoids.From1 Mar 2023 → 29 Feb 2024Funding: Nonprofit institution or equivalents
- Detection and quantification of a panel of clinically relevant DNA biomarker sequences containing KRAS mutations in tissue and liquid biopsies via a novel photoelectrochemical technology.From1 Jan 2023 → TodayFunding: FWO Humanitarian research project Stand up against Cancer
- Multiplexed photoelectrochemical detection technology for molecular cancer biomarkers (MultiSens).From1 Jan 2023 → 31 Dec 2023Funding: IOF - technology validation in lab
- A new photoelectrochemical singlet oxygen-based detection platform for a panel of cancer biomarkers in tissue and liquid biopsies (SOCAN).From1 Jan 2023 → TodayFunding: BOF - iBOF, University - Project driven research
- Improving diagnostic accuracy and follow-up of neuroendocrine neoplasms through detection of (epi)genetic biomarkers in liquid biopsies using novel technological platforms.From1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Investigation to reveal the immune reaction upon COVID vaccination in the Belgian cancer population: COVID protection and vaccine safety (REAL-V).From1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- Towards informed decisions in colorectal cancer screening (ORIENT).From15 Aug 2022 → TodayFunding: Nonprofit institution or equivalents
- Center for Proteomics (CfP).From1 Jan 2022 → TodayFunding: BOF - research organisations
Publications
281 - 290 of 385
- Radionuclide imaging of annexins(2014)
Authors: Christel Vangestel, Leonie Wyffels, Marc Peeters, Steven Staelens, Sigrid Stroobants
Pages: 622 - 638 - Liquid biopsies in lung cancer(2014)
Authors: Christian Rolfo, Marta Castiglia, David Hong, Riccardo Alessandro, Inge Mertens, Geert Baggerman, Karen Zwaenepoel, Ignacio Gil-Bazo, Francesco Passiglia, Anna P. Carreca, et al.
Pages: 539 - 546 - Status of active specific immunotherapy for stage II, stage III, and resected stage IV colon cancer(2013)
Authors: Evelien Smits, Marc Peeters, Jan Vermorken
Pages: 380 - 390 - Dilemma in metastatic colorectal cancer(2013)
Authors: Christian Rolfo, Antonio Russo, Daniele Santini, Giuseppe Bronte, Marc Peeters
Pages: 869 - 871 - Benchmarking and audit of breast units improves quality of care(2013)
Authors: Peter Van Dam, L. Verkinderen, J. Hauspy, Peter Vermeulen, Luc Dirix, Manon Huizing, S. Altintas, K. Papadimitrou, Marc Peeters, Wiebren Tjalma
Pages: 26 - 33 - Antineoplastic therapy-induced pulmonary toxicity(2013)
Authors: Anna Sadowska, Pol Specenier, Paul Germonpre, Marc Peeters
Pages: 997 - 1006 - TNF-$\alpha$ gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy(2013)
Authors: M. Roselli, P. Ferroni, Christian Rolfo, Marc Peeters, et al.
Pages: 2571 - 2575 - Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer(2013)
Authors: Ridha Limame, Ken Op de Beeck, Steven Van Laere, Lieselot Croes, Annemieke De Wilde, Luc Dirix, Guy Van Camp, Marc Peeters, Olivier De Wever, Filip Lardon, et al.
Pages: 69 - 81 - A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma(2013)
Authors: Marc Peeters, A.H. Strickland, M. Lichinitser, et al.
Pages: 503 - 511 - Targeted therapy in metastatic colorectal cancer - An example of personalised medicine in action(2013)
Authors: V. Heinemann, J. Y. Douillard, M. Ducreux, Marc Peeters
Pages: 592 - 601
Patents
1 - 6 of 6
- Combination immunotherapy of il-15 and cd40 agonist in cancer treatment (Inventor)
- Combination immunotherapy of IL-15 and CD40 agonist in cancer treatment (Inventor)
- Methylation detection assay (Inventor)
- Methylation status of gasdermin E gene as cancer biomarker (Inventor)
- Combination immunotherapy of IL-15 and CD40 agonist in cancer treatment (Inventor)
- Methylation status of gasdermin e gene as cancer biomarker (Inventor)